LOVASTATIN | N021316 | AZURITY PHARMACEUTICALS SWITZERLAND GMBH
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
FDA/CFSAN Response to Pharmanex Inc - Answer FDA-1997-P-0065 · 16 docket documents Pharmanex Inc filed this administrative petition regarding Cholestin, a red yeast rice product containing lovastatin, seeking FDA confirmation that the product qualifies as a dietary supplement. The FDA concluded that Cholestin is not a dietary supplement but rather an unapproved new drug under the | Other | 2009-01-07 | Open | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.